Goldman Sachs India Equity ETF
GIND - ETF AI Analysis
Top Page
Goldman Sachs India Equity ETF (GIND)
GIND, the Goldman Sachs India Equity ETF, earns a solid overall rating largely because it is anchored by strong Indian banks like ICICI Bank and HDFC Bank, which show robust growth, profitability, and supportive technical trends. Reliance Industries and Sun Pharma also add strength with solid financial performance and generally bullish momentum, though high valuations and some overbought or bearish signals in names like Reliance and Bajaj Finance introduce risk. The main risk factor is the fund’s heavy tilt toward financials and a few large Indian corporates, which can make performance more sensitive to sector-specific and valuation-related swings.
GIND vs. SPDR S&P 500 ETF (SPY)
- AUM
- 171.19M
- Region
- Asia-Pacific
- Expense Ratio
- 0.75%
- Beta
- 0.57
- Issuer
- Goldman Sachs
- Inception Date
- Apr 01, 2025
- Dividend Yield
- 0.68%
- Asset Class
- Equity
- Index Tracked
- MSCI India IMI
GIND Summary
The Goldman Sachs India Equity ETF (GIND) is an actively managed fund that invests in a wide range of Indian stocks, following the MSCI India IMI index as its main guide. It holds many types of companies, from big banks and energy firms to tech and consumer businesses. Well-known names include ICICI Bank, HDFC Bank, Reliance Industries, and Tata Consultancy Services. Someone might invest in GIND to tap into India’s long-term growth and to diversify beyond U.S. markets. A key risk is that it is heavily focused on India, so its value can rise or fall sharply with changes in the Indian economy and stock market.
How much will it cost me?
This ETF has an expense ratio of 0.75%, which means you’ll pay about $7.50 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, with professionals selecting and adjusting Indian stocks rather than simply tracking a broad market index.
What would affect this ETF?
GIND could benefit from continued economic growth in India, rising incomes, and expansion in banking, energy, and technology, which support its broad exposure and top holdings like major Indian banks, Reliance Industries, and Tata Consultancy Services. On the negative side, higher global interest rates, slower growth in India, currency swings, or changes in local regulations and government policy could hurt Indian stocks, especially financials and smaller companies that make up much of this ETF.
GIND Top 10 Holdings
GIND is leaning heavily on India’s big private banks, with ICICI Bank and Kotak Mahindra Bank acting as key engines of recent gains as their shares have been rising or holding steady. In contrast, HDFC Bank and Axis Bank have been lagging, softening the overall financials story. Reliance Industries and Mahindra & Mahindra add industrial and energy flavor but have shown mixed, sometimes weaker momentum, while Zomato offers a more upbeat, growth-oriented note. Overall, this is a India-only play, concentrated in domestic financials with a sprinkling of consumer and industrial names.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ICICI Bank Limited | 6.15% | $10.63M | INR 11.27T | 16.88% | 71Outperform | |
| HDFC Bank Limited | 3.60% | $6.23M | INR 12.48T | -17.95% | 79Outperform | |
| Reliance Industries Limited | 2.97% | $5.14M | INR 18.04T | -11.75% | 74Outperform | |
| Mahindra & Mahindra Ltd. | 2.72% | $4.70M | INR 4.30T | -9.19% | 68Neutral | |
| Axis Bank Limited | 2.66% | $4.59M | INR 4.17T | 9.34% | 76Outperform | |
| Kotak Mahindra Bank Limited | 2.41% | $4.16M | INR 4.85T | 17.40% | ―― | |
| Bajaj Finance Limited | 2.31% | $3.99M | INR 6.69T | 9.76% | 64Neutral | |
| Zomato Ltd. | 2.08% | $3.60M | INR 3.48T | 17.84% | ―― | |
| Sun Pharmaceutical Industries Limited | 1.89% | $3.26M | INR 4.55T | 8.95% | 73Outperform | |
| Divi's Laboratories Limited | 1.84% | $3.19M | INR 3.00T | 75.63% | 74Outperform |
GIND Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GIND, the sentiment is Positive. The current price of 25.63 is above the 20-day moving average (MA) of 24.12, above the 50-day MA of 24.03, and above the 200-day MA of 23.98, indicating a bullish trend. The MACD of 0.45 indicates Negative momentum. The RSI at 73.41 is Negative, neither overbought nor oversold. The STOCH value of 95.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GIND.
GIND Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $25.63 | $24.50(-4.41% Downside) | $171.19M | 0.75% | 56Neutral | |
| $51.55 | $57.30(11.15% Upside) | $6.88B | 0.61% | 66Neutral | |
| $36.79 | $40.71(10.64% Upside) | $2.79B | 0.19% | 65Neutral | |
| $71.26 | ― | $737.70M | 0.74% | 59Neutral | |
| $45.96 | $51.78(12.65% Upside) | $601.82M | 0.65% | 67Neutral | |
| $55.88 | $61.54(10.13% Upside) | $110.24M | 0.80% | 64Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GIND | Goldman Sachs India Equity ETF | 25.63 | -0.99 | -3.73% | |
| INDA | iShares MSCI India ETF | 51.55 | -3.10 | -5.67% | |
| FLIN | Franklin FTSE India ETF | 36.79 | -2.20 | -5.65% | |
| SMIN | iShares MSCI India Small Cap ETF | 71.26 | -1.11 | -1.54% | |
| INDY | iShares India 50 ETF | 45.96 | -3.28 | -6.66% | |
| NFTY | First Trust India NIFTY 50 Equal Weight ETF | 55.88 | -2.27 | -3.90% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
